| P2093 | author name string | Lei Zhang | |
| | Jia-Li Liu | |
| | Yu-Mei Wang | |
| | Zu-Wang Liu | |
| P2860 | cites work | Assessing the quality of reports of randomized clinical trials: is blinding necessary? | Q27860973 |
| | Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden | Q28209970 |
| | Cholinesterase inhibitors and hospitalization for bradycardia: a population-based study | Q28476190 |
| | A new method of classifying prognostic comorbidity in longitudinal studies: development and validation | Q29547376 |
| | Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses | Q29619185 |
| | Reader's guide to critical appraisal of cohort studies: 2. Assessing potential for confounding | Q33937132 |
| | Oxycodone: a review of its use in the management of pain | Q34718317 |
| | Trends in opioid use and dosing among socio-economically disadvantaged patients. | Q35496564 |
| | Cancer Pain | Q35581638 |
| | Trends in long-term opioid therapy for chronic non-cancer pain | Q35758775 |
| | Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: systematic review and meta-analysis of randomized controlled trials | Q36171579 |
| | Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force | Q36372988 |
| | Oxycodone for cancer-related pain: meta-analysis of randomized controlled trials. | Q36459019 |
| | Oxycodone: a pharmacological and clinical review | Q36831469 |
| | Role of oxycodone and oxycodone/naloxone in cancer pain management | Q37795441 |
| | A systematic review of oxycodone in the management of cancer pain | Q37894992 |
| | Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes | Q39307077 |
| | Efficacy and tolerability of oxycodone hydrochloride controlled-release tablets in moderate to severe cancer pain | Q39338295 |
| | Management of cancer pain: ESMO Clinical Practice Guidelines | Q43016572 |
| | Opioid analgesics and rates of fatal drug poisoning in the United States | Q44333232 |
| | Trends in the consumption of opioid analgesics in Spain. Higher increases as fentanyl replaces morphine | Q44337320 |
| | When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function | Q48821181 |
| | Biased Selection of Controls for Case-Control Analyses of Cohort Studies | Q52873601 |
| P433 | issue | 2 | |
| P304 | page(s) | 249-254 | |
| P577 | publication date | 2010-05-10 | |
| P1433 | published in | Experimental and Therapeutic Medicine | Q23979083 |
| P1476 | title | Efficacy and tolerability of oxycodone in moderate-severe cancer-related pain: A meta-analysis of randomized controlled trials | |
| P478 | volume | 4 | |